Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

August 23, 2016August 23, 2016

Cough App That Diagnoses Pneumonia, Other Respiratory Diseases to Be Tested in US

Perth-based Resapp Health, the company that developed an innovative cough-interpreting smartphone app that diagnoses certain respiratory diseases such as pneumonia better than a stethoscope, aims to repeat the success of its West ... Read more

August 22, 2016

Study Examines Pneumonia Hospitalizations in Scotland After PCV Immunization

Researchers in Scotland have found that health care planners cannot predict indirect pneumococcal conjugate (PCV) vaccine impacts on hospitalizations rates. According to the study, invasive pneumococcal disease surveillance across all age groups is ... Read more

July 26, 2016July 26, 2016

7-Part ‘Score’ Helps Predict Risk of Pneumonia in Older Adults

Researchers have developed a “prediction score” to help healthcare professionals determine which older adults might be most at risk for developing pneumonia. The study detailing the score, “Predicting 2-Year Risk ... Read more

July 1, 2016July 1, 2016

Data on Pneumococcal Disease Vaccine Trial Presented at International Symposium

ImmunoBiology recently reported positive data from its first in human clinical trial (NCT02572635) on PnuBioVax, a vaccine targeting pneumococcal disease that utilizes the company’s ImmBioVax technology. Streptococcus pneumoniae is a type of bacteria that can ... Read more

May 20, 2016May 20, 2016

Results from Breo Ellipta Clinical Trial in COPD Patients Presented by GSK

GlaxoSmithKline recently presented new data from two analyses of the SUMMIT trial, a study that evaluated the impact of Breo Ellipta (fluticasone furoate/vilanterol or FF/VI 100/25 mcg) on the survival of patients ... Read more

May 17, 2016May 17, 2016

Pneumonia Vaccination Gets Boost with 2-Minute Video from Northwestern Medicine Researchers

Results from a Northwestern Medicine study showed that a two-minute video concerning pneumococcal vaccination sent to patients before a primary care appointment tripled the likelihood of patients getting the vaccine. The vaccination ... Read more

May 6, 2016May 6, 2016

CHMP Favors EU Approval of CAZ AVI Antibiotic to Treat Serious Bacterial Infections

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of CAZ AVI 2g/0.5g formulation for the ... Read more

May 4, 2016May 4, 2016

NDA Submission Complete for Bacterial Pneumonia Treatment of Solithromycin, Cempra Announces

Cempra Inc. announced it has completed submissions to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for its lead product candidate solithromycin for the treatment of ... Read more